Dependency of standardized uptake values of fluorine-18 fluorodeoxyglucose on body size comparison of body surface area correction and lean body mass correction

Nuclear Medicine Communications

Volumn 17, Issue 10, 1996, Pages 890-894

  Kim, Chun K ^a   Gupta, N C ^b  

^a Mount Sinai Hospital and School of Medicine   (Germany)

^b WEST VIRGINIA UNIVERSITY HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ABDOMINAL CANCER; ADULT; AGED; ARTICLE; BODY SIZE; BODY WEIGHT; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; MALE; OVARY CANCER; PELVIS CANCER; POSITRON EMISSION TOMOGRAPHY;

EID: 0029845837     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199610000-00011     Document Type: Article

References (19)

1. Di Chiro G, DeLaPaz RL, Brooks RA et al Glucose utilization of cerebral gliomas measured by 18-F-fluoro-deoxy-glucose and positron emission tomography. Neurology 1982; 32: 1323-1329.
2. Di Chiro G. Positron emission tomography using [18F]fluorodeoxyglucose in brain tumors. Invest Radiol 1987; 22: 360-371.
3. Tyler JL, Diksic M, Villemure J-G et al Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. J Nucl Med 1987; 28: 1123-1133.
4. Okada J, Yoshikawa K, Itami M et al Positron emission tomography using fluorine-18 fluorodeoxy glucose in malignant lymphoma: A comparison with proliferative activity. J Nucl Med 1992; 33: 325-329.
5. Okazumi S, Isono K, Enomoto K et al Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: Characterization of tumor and assessment of effect of medicine. J Nucl Med 1992; 33: 333-339.
6. Di Chiro G, Brooks RA. PET quantitation: Blessing and curse. J Nucl Med 1988; 29: 1603-1604.
7. Patronas NJ, Di Chiro G, Brooks RA et al. [18F] Fluoro-deoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology 1982; 144: 885-889.
8. Alavi JB, Alavi A, Chawluk J et al. Positron emission tomography in patients with glioma: A prediction of prognosis. Cancer 1988; 62: 1074-1078.
9. Kim CK, Alavi JB, Alavi A, Reivich M. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. J Neuro-Oncol 1991; 10: 85-91.
10. Wahl RL, Cody RL, Hutchins GD, Mudgett EE. Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-D-glucose. Radiology 1991; 179: 767-770.
11. Griffeth LK, Dehdashti F, McGuire AH et al. PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose. Radiology 1992; 182: 185-194.
12. Gupta NC, Frank AR, Dewan NA et al Solitary pulmonary nodules: Detection of malignancy with PET with 2-[F-18] fluoro-2-deoxy-D-glucose. Radiology 1992; 184: 441-444.
13. Haberkom U, Strauss LG, Dimitrakopoulou A et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991; 32: 1485-1490.
14. Adler LP, Blair HF, Makley JT et al. Noninvasive grading of musculoskeletal tumors using PET. J Nucl Med 1991; 32: 1508-1512.
15. Strauss LG, Conti PS. The application of PET in clinical oncology. J Nucl Med 1991; 32: 623-648.
16. Zasadny K, Wahl RL. Standardized uptake values of normal tissues at FDG-PET: Variations with body weight (abstract). Radiology 1992; 185: 186.
17. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: Variations with body weight and a method for correction. Radiology 1993; 189: 847-850.
18. Kim CK, Gupta N, Chandramouli B, Alavi A. Standardized uptake values of FDG: Body surface area correction is preferable to body weight correction. J Nucl Med 1994; 35: 164-167.
19. Dubois D, Dubois EF. Clinical calorimetry: Tenth paper. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-871.